Stock Scorer

Cerenome, Inc. (PSTV)

Cerenome, Inc. reported revenue of 411K USD for the quarter ending 30 June 2026, down 70.4% from 1.4M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 411K -70.4%
Gross Profit Q3 '18 · ending 30 September 2018 230K —
Operating Income Q2 '26 · ending 30 June 2026 -9.1M —
Net Income Q2 '26 · ending 30 June 2026 -9M -274.8%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -7.1M —
Free Cash Flow Q2 '26 · ending 30 June 2026 -7.6M —
Shares Outstanding Q2 '26 · ending 30 June 2026 6.9M +1084.0%
EPS Q1 '25 · ending 31 March 2025 -31.61 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 5.2M-15.3M-22.4M-20.8M
20242024-12-31 5.8M-14.7M-13M-10.7M
20232023-12-31 4.9M-13.3M-13.3M-13M
20182018-12-31 3.7M-8.8M-12.6M-12.1M
20172017-12-31 2.7M-20.7M-22.7M-18.4M
20162016-12-31 4.7M-19.7M-22M-19.6M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30411K
Q1 '262026-03-311M
Q4 '252025-12-311.4M
Q3 '252025-09-301.4M
Q2 '252025-06-301.4M
Q1 '252025-03-311.1M
Q4 '242024-12-311.4M
Q3 '242024-09-301.5M
Q2 '242024-06-301.3M
Q1 '242024-03-311.7M
Q1 '192019-03-31703K
Q4 '182018-12-311.4M
Q3 '182018-09-30858K
Q2 '182018-06-30660K
Q1 '182018-03-31731K
Q4 '172017-12-31662K
Q3 '172017-09-30467K
Q2 '172017-06-30969K
Q1 '172017-03-31591K
Q4 '162016-12-311.5M

Gross Profit Quarterly

PeriodEndingGross Profit
Q3 '182018-09-30230K
Q2 '182018-06-3030K
Q1 '182018-03-31152K
Q4 '172017-12-3129K
Q3 '172017-09-30-20K
Q2 '172017-06-30262K
Q1 '172017-03-31-125K
Q4 '162016-12-31521K
Q3 '162016-09-30113K
Q2 '162016-06-30541K
Q1 '162016-03-31766K
Q4 '152015-12-31765K
Q3 '152015-09-30264K
Q2 '152015-06-30318K
Q1 '152015-03-31304K
Q4 '142014-12-311.1M
Q3 '142014-09-30181K
Q2 '142014-06-30169K
Q1 '142014-03-31610K
Q4 '132013-12-311.6M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-9.1M
Q1 '262026-03-31-7.1M
Q4 '252025-12-31-5.7M
Q3 '252025-09-30-4.5M
Q2 '252025-06-30-1.5M
Q1 '252025-03-31-3.5M
Q4 '242024-12-31-3.9M
Q3 '242024-09-30-3.8M
Q2 '242024-06-30-3.7M
Q1 '242024-03-31-3.3M
Q4 '232023-12-31-3.9M
Q3 '232023-09-30-3.3M
Q2 '232023-06-30-1.5M
Q1 '232023-03-31-4.7M
Q4 '222022-12-31-5.6M
Q3 '222022-09-30-5.1M
Q2 '222022-06-30-5.1M
Q1 '222022-03-31-3.9M
Q4 '212021-12-31-3.9M
Q3 '212021-09-30-3.5M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-9M
Q1 '262026-03-31-6.9M
Q4 '252025-12-31-5.7M
Q3 '252025-09-30-4.4M
Q2 '252025-06-305.2M
Q1 '252025-03-31-17.4M
Q4 '242024-12-31-3.9M
Q3 '242024-09-30-2.9M
Q2 '242024-06-30-2.9M
Q1 '242024-03-31-3.3M
Q4 '232023-12-31-3.8M
Q3 '232023-09-30-3.2M
Q2 '232023-06-30-1.5M
Q1 '232023-03-31-4.8M
Q4 '222022-12-31-5.7M
Q3 '222022-09-30-5.2M
Q2 '222022-06-30-5.3M
Q1 '222022-03-31-4.1M
Q4 '212021-12-31-4.2M
Q3 '212021-09-30-3.7M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-7.1M
Q1 '262026-03-31-6.2M
Q4 '252025-12-31-6.3M
Q3 '252025-09-30-2.5M
Q2 '252025-06-30-5.8M
Q1 '252025-03-31-6.2M
Q4 '242024-12-31-1.2M
Q3 '242024-09-30-3.7M
Q2 '242024-06-30-1.1M
Q1 '242024-03-31-4.5M
Q4 '232023-12-31-1.9M
Q3 '232023-09-30-2.4M
Q2 '232023-06-30-2.8M
Q1 '232023-03-31-5.8M
Q4 '222022-12-31-2.2M
Q3 '222022-09-30-4.2M
Q2 '222022-06-30-2.6M
Q1 '222022-03-31-3.9M
Q4 '212021-12-31-2.6M
Q3 '212021-09-30-2.3M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-7.6M
Q1 '262026-03-31-7.1M
Q4 '252025-12-31-6.3M
Q3 '252025-09-30-2.6M
Q2 '252025-06-30-5.8M
Q1 '252025-03-31-6.2M
Q4 '242024-12-31-1.2M
Q3 '242024-09-30-3.7M
Q2 '242024-06-30-1.2M
Q1 '242024-03-31-4.6M
Q4 '232023-12-31-1.9M
Q3 '232023-09-30-2.4M
Q2 '232023-06-30-2.8M
Q1 '232023-03-31-5.9M
Q3 '222022-09-30-4.3M
Q2 '222022-06-30-2.8M
Q1 '222022-03-31-4.1M
Q3 '212021-09-30-2.3M
Q2 '212021-06-30-2.4M
Q1 '212021-03-31-3.1M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-306.9M
Q1 '262026-03-316.6M
Q3 '252025-09-30107.4M
Q2 '252025-06-308.4M
Q1 '252025-03-31582.7K
Q3 '242024-09-307.9M
Q2 '242024-06-3010.7M
Q1 '242024-03-314.3M
Q3 '232023-09-303.2M
Q2 '232023-06-302.5M
Q1 '232023-03-312.3M
Q3 '222022-09-301.8M
Q2 '222022-06-301.5M
Q1 '222022-03-3121.5M
Q3 '212021-09-3013.3M
Q2 '212021-06-3011.3M
Q3 '162016-09-3020.5M
Q2 '162016-06-3014.8M
Q3 '152015-09-3010.5M
Q2 '152015-06-309.8M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q1 '252025-03-31-31.61
Q4 '242024-12-31-2.50
Q3 '242024-09-30-2.53
Q2 '242024-06-30-3.16
Q1 '242024-03-31-3.04
Q4 '232023-12-31-4.36
Q3 '232023-09-30-6.02
Q2 '232023-06-30-7.87
Q1 '232023-03-31-10.84
Q4 '222022-12-31-8.96
Q3 '222022-09-30-6.87
Q2 '222022-06-30-4.30
Q1 '222022-03-31-0.99
Q4 '212021-12-31-1.13
Q3 '212021-09-30-1.59
Q2 '212021-06-30-1.70
Q1 '212021-03-31-1.90
Q4 '202020-12-31-1.85
Q3 '202020-09-3020.23
Q2 '202020-06-3020.59